Cardiac Transplant
7
0
1
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
28.6%
2 terminated out of 7 trials
50.0%
-36.5% vs benchmark
29%
2 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Expanding the Pool in Orthotopic Heart Transplantation
Daratumumab in HLA Desensitization Prior to Transplantation
Cytokine Profiling Post-Heart Transplant
DEtection of Cellular Inflammation With FERumoxytol in the HEART
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide
The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant